Anti-TIFA (phospho T9) antibody [EPR19853] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal TIFA phospho T9 antibody. Carrier free. Suitable for IP, Dot, WB and reacts with Human, Synthetic peptide, Transfected cell lysate samples. Cited in 1 publication.
View Alternative Names
T2BP, TIFA, TRAF-interacting protein with FHA domain-containing protein A, Putative MAPK-activating protein PM14, Putative NF-kappa-B-activating protein 20, TRAF2-binding protein
- IP
Supplier Data
Immunoprecipitation - Anti-TIFA (phospho T9) antibody [EPR19853] - BSA and Azide free (AB236848)
TIFA (phospho T9) was immunoprecipitated from 0.35 mg HEK-293T (human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell lysate with ab214815 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab214815 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/5000 dilution.
Lane 1 : HEK-293T transfected with GFP-tagged TIFA expression vector for 24 hours, and then infected with B. cenocepacia J2315 for 4 hours whole cell lysate 10 μg (Input).
Lane 2 : ab214815 IP in HEK-293T transfected with GFP-tagged TIFA expression vector for 24 hours, and then infected with B. cenocepacia J2315 for 4 hours whole cell lysate (+).
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab214815 in HEK-293T transfected with GFP-tagged TIFA expression vector for 24 hours, and then infected with B. cenocepacia J2315 for 4 hours whole cell lysate (-).
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : 3 minutes.
The lysates were kindly provided by our collaborator Dr Feng Shao's lab, NIBS.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab214815).
All lanes:
Immunoprecipitation - Anti-TIFA (phospho T9) antibody [EPR19853] (<a href='/en-us/products/primary-antibodies/tifa-phospho-t9-antibody-epr19853-ab214815'>ab214815</a>)
Predicted band size: 21 kDa,43 kDa
Observed band size: 16 kDa,42 kDa,43 kDa
false
- WB
Collaborator
Western blot - Anti-TIFA (phospho T9) antibody [EPR19853] - BSA and Azide free (AB236848)
Blocking/Dilution buffer : 5% milk/TBST.
The image was kindly provided by our collaborator Dr Feng Shao's lab, NIBS.
S. flexneri infection induces an innate immune response (PMID : 28222186).
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol and sodium azide (ab214815).
All lanes:
Western blot - Anti-TIFA (phospho T9) antibody [EPR19853] (<a href='/en-us/products/primary-antibodies/tifa-phospho-t9-antibody-epr19853-ab214815'>ab214815</a>) at 1/1000 dilution
Lane 1:
HeLa (Human epithelial cell line from cervix adenocarcinoma) transfected with 3×Flag-tagged TIFA expression vector for 28 hours, whole cell lysate at 20 µg
Lane 2:
HeLa transfected with 3×Flag-tagged TIFA T9A mutant expression vector for 28 hours, whole cell lysate at 20 µg
Lane 3:
HeLa transfected with 3×Flag-tagged TIFA expression vector for 24 hours, and then infected with S. flexneri 2457T for 4 hours, whole cell lysate at 20 µg
Lane 4:
HeLa transfected with 3×Flag-tagged TIFAT9A mutant expression vector for 24 hours, and then infected with S. flexneri 2457T for 4 hours, whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/5000 dilution
Predicted band size: 21 kDa
Observed band size: 26 kDa
false
Exposure time: 30s
- Dot
Supplier Data
Dot Blot - Anti-TIFA (phospho T9) antibody [EPR19853] - BSA and Azide free (AB236848)
Dot blot analysis of TIFA (phospho T9) labeled with ab214815 at 1/1000 dilution.
Lane 1 : TIFA (phospho T9) peptide (aa3-12).
Lane 2 : TIFA (phospho T9) peptide (aa5-15).
Lane 3 : TIFA non-phospho peptide (aa3-15).
Secondary used was Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1/100000 dilution.
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : 10 seconds.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab214815).
Reactivity data
Product details
ab236848 is the carrier-free version of ab214815.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
TIFA acts as a mediator in various cellular responses by forming signaling complexes. It possesses a threonine-phosphorylation motif necessary for the formation of oligomeric structures which facilitates its interactions with other proteins. Through this TIFA participates in immune response and inflammation regulation contributing to cellular resilience against external stresses.
Pathways
TIFA is an important player in the NF-κB signaling and Toll-like receptor pathways. It regulates protein interactions within these pathways such as TRAF2 and TRAF6 that help propagate proinflammatory signals. The induction of TIFA in these pathways leads to the activation of downstream effectors which result in targeted immune responses.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in oncology 12:955510 PubMed36119517
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com